Skip to content

Life Science & Healthcare

China is an increasingly attractive market for Danish medical, Life Science and HealthTech companies.

Dancing people
© 2013 Jens Schott Knudsen | blog.pamhule.com | Twitter: @jensschott

A demand for innovative solutions

China is aiming to become a significant player in the Life Science & Healthcare industry. At the same time, the Chinese welfare system is under pressure with a rapidly increasing middleclass financially able to seek better welfare for themselves and their family. This calls for innovative thinking and rethinking and the demand for new technologies and partnerships is high and the governmental support is strong.

International and domestic companies are positioning themselves as links in the global supply chain of Life Science & Healthcare, native companies are behaving more far-sighted, and research has become more collaborative. This creates a favourable business environment for Danish companies in the industry.

New policies pushing forward the industry

In 2016, China released their Healthy China 2030 blueprint that promotes environment management, public health, the medical industry and drug safety. The goal is to “intervene in health influencing factors, protect full-life-cycle health and prevent and control major diseases”.

Furthermore, in 2018, The Chinese National Health Commission issued the Measures for the Administration of Internet Hospital encouraging hospitals to establish internet platform and seek permission to run it. By summer 2019, the number of hospitals qualified to provide digital healthcare services is already 158.

Danish opportunities in Chinese Life Science & Healthcare

Denmark leads the way in Europe when it comes to clinical research, it has high-level biotechnology development competencies of international class and is one of the biggest medical technology industries globally according to export per capita. A reason behind this is the close and encouraged collaboration between private and public actors in Denmark, as well as the political focus of nurturing the optimal environment for innovation, research and development.

All of these characterstics of the Danish Life Science & Healthcare industry is highly valued by the Chinese government. Whether you are looking for further business development with Chinese partners or need to develop your market entry strategy, we are ready to help you. We assist start-ups, SMEs, and bigger companies and we utilise our in-depth sector expertise and network to deliver tailor made services.

Contact our Life Science Innovation Officer

Yu Qi
Tel: (+86 21) 8025 0626
Email: yuxqix@um.dk
LinkedIn